Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths
11:16am, Tuesday, 31'st Mar 2026
The FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to Tavneos.
US FDA warns of liver injury cases tied to Amgen's rare disease drug
11:07am, Tuesday, 31'st Mar 2026
The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen's drug for a group of rare autoimmune diseases and urged healthcare providers �
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
05:56am, Tuesday, 31'st Mar 2026
AMGN, T, and Roche shares outperform as strong drug portfolios and wireless momentum offset key headwinds like pricing pressure and legacy declines.
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN
05:10am, Tuesday, 31'st Mar 2026
Financial Planning Hawaii Inc. purchased a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Comm
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN
04:36am, Tuesday, 31'st Mar 2026
Brookstone Capital Management lifted its position in Amgen Inc. (NASDAQ: AMGN) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Beacon Investment Advisory Services Inc. Grows Stock Holdings in Amgen Inc. $AMGN
03:34am, Monday, 30'th Mar 2026
Beacon Investment Advisory Services Inc. raised its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Excha
Chesley Taft & Associates LLC Increases Position in Amgen Inc. $AMGN
04:33am, Sunday, 29'th Mar 2026
Chesley Taft and Associates LLC grew its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 14.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fu
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
04:45pm, Saturday, 28'th Mar 2026
Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:02am, Friday, 27'th Mar 2026
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Amgen Inc. $AMGN Shares Purchased by Czech National Bank
04:43am, Thursday, 26'th Mar 2026
Czech National Bank raised its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 3.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
06:51pm, Wednesday, 25'th Mar 2026
In the most recent trading session, Amgen (AMGN) closed at $353.93, indicating a +1.58% shift from the previous trading day.
Amgen Inc. $AMGN Shares Sold by Diversified Trust Co.
03:24pm, Tuesday, 24'th Mar 2026
Diversified Trust Co. lessened its stake in Amgen Inc. (NASDAQ: AMGN) by 5.5% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 40,349 shares of the medical re
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN
02:08pm, Tuesday, 24'th Mar 2026
Clear Trail Advisors LLC purchased a new position in shares of Amgen Inc. (NASDAQ: AMGN) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock?
01:20pm, Thursday, 19'th Mar 2026
Amgen stock holds above key SMAs as strong drug sales, biosimilars, and MariTide pipeline momentum offset looming patent losses and pricing headwinds.
Coldstream Capital Management Inc. Has $4.92 Million Holdings in Amgen Inc. $AMGN
04:16am, Thursday, 19'th Mar 2026
Coldstream Capital Management Inc. decreased its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 12.3% during the third quarter, according to the company in its most recent filing with the SEC. The fu
